Seasoned healthcare executive added as Bodyport commercial efforts ramp up SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, announced today the appointment of Jim Pursley to the company’s board of directors. “I am excited to join the Bodyport Board of Directors as […]

Medtech industry veteran to lead Bodyport market entry and growth of noninvasive tool to assess heart function and fluid status easily at home SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, today announced the appointment of medtech industry veteran, John Lipman, as Chief Executive […]

SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, the digital health company focused on the detection and management of heart disease, today announced that it has named Amit Rushi as Chief Commercial Officer (CCO) and Phyllis Whiteley as Chair of the Board of Directors. With this newly created role, Amit Rushi will serve as part […]

Investments from Boehringer Ingelheim Venture Fund (BIVF), Playground Global and Initialized Capital will advance the prevention and management of heart disease SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, the digital health company focused on the detection and management of heart disease, today announced the close of an $11.2 million Series A investment round. Boehringer […]